Catalent (NYSE: CTLT) to Sell Oral Drug Development Site in New Jersey to Ardena
Catalent (NYSE: CTLT) has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to […]
Catalent (NYSE: CTLT) to Sell Oral Drug Development Site in New Jersey to Ardena Read More »
